Novel acetylcholinesterase reactivator K112 and its cholinergic properties

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
O SoukupK Kuca

Abstract

The oxime reactivator K112 is a member of the new group of xylene linker-containing AChE reactivators. Its cholinergic properties could be of importance at OP poisoning and are not related to the AChE reactivation that has been studied. It has been found that, despite of reactivating potency, this compound has additional effects. These cholinergic effects include a weak inhibition of AChE (IC(50)=43.8 ± 4.88 μM), inhibition of binding to the porcine muscarinic M2 receptor (IC(50)=4.36 μM) and finally, the inhibition of HACU (68.4 ± 9.9%), a key regulatory step in the synthesis of ACh. The inhibition of the binding of (3H)-HC-3 (64.7 ± 4.7%) and the influence on the membrane fluidity have also been observed. Blocking properties of K112 on the muscarinic receptors have been revealed in the in vitro experiment (rat urinary bladder) and in the in vivo experiment (rat heart BPM) as well. All these cholinergic properties could significantly contribute to the antidotal effect of K112 at the poisoning by the organophosphates.

References

Jan 1, 1989·Archives of Toxicology·M G Hamilton, P M Lundy
Jan 1, 1985·Journal of Neurochemistry·S Tucek
Jan 1, 1996·Archives of Toxicology·H P van HeldenP L Bruijnzeel
Mar 21, 2001·Methods and Findings in Experimental and Clinical Pharmacology·H OguraY Yamanishi
Jun 18, 2002·European Journal of Pharmacology·Weng-Keong LokeMei-Lin Go
Dec 12, 2002·Journal of Toxicology. Clinical Toxicology·J Kassa
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Jun 22, 2005·European Journal of Pharmacology·Ole Kristian ØydvinPål Aas
Dec 30, 2006·Journal of Enzyme Inhibition and Medicinal Chemistry·Martina HrabinovaKamil Kuca
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Daniel GiglioGunnar Tobin
Nov 7, 2008·Neuro Endocrinology Letters·Ondrej SoukupKamil Kuca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.